NHL	non-Hodgkin lymphoma
B-NHL	B-cell non-Hodgkin lymphoma
BL	Burkitt lymphoma
DLBCL	diffuse large B-cell lymphoma
CNS	central nervous system
OS	overall survival
mAb	monoclonal antibody
ICI	immune checkpoint inhibitor
ADC	antibody–drug conjugate
CAR	chimeric antigen receptor
MHC	major histocompatibility complex
CD	cluster of differentiation
TCR	T cell receptor
ITAM	immuno-tyrosine activation motif
ICOS	inducible T cell co-stimulator
IL	interleukin
FDA	Food and Drug Administration
EMA	European Medicines Agency
R/R	relapsed or refractory
ORR	overall response rate
CRR	complete response rate
CR	complete response
PRR	partial response rate
PR	partial response
DOR	duration of response
PFS	progression-free survival
CRS	cytokine release syndrome
FL	follicular lymphoma
LBCL	large B-cell lymphoma
tisa-cel	tisagenlecleucel
HGBCL	high-grade B-cell lymphoma
tFL	transformed follicular lymphoma
auto-HSCT	autologous hematopoietic stem-cell transplantation
ALL	acute lymphoblastic leukemia
axi-cel	axicabtagene ciloleucel
KTE	X19-Brexucabtagene autoleucel
liso-cel	lisocabtagene maraleucel
DLT	dose-limiting toxicities
CLL	chronic lymphocytic leukemia
SLL	small lymphocytic lymphoma
LDH	lactate dehydrogenase
HRQoL	health-related quality of life
EORTC	QLQ-C30-European Organization for Research and Treatment of Cancer Quality of Life Questionnaire
QoL	Quality of Life
PET	Positron-Emission Tomography
PET-CT-Positron	Emission Tomography and Computed Tomography
PTLD-post-transplant	B-cell lymphoproliferative disorder
allo-HSCT-allogeneic	hematopoietic stem cell transplantation
ctDNA-cell-free	circulating tumor DNA
AE-adverse	effect
ICANS	immune effector cell-associated neurotoxicity syndrome
CRES	CAR-T-cell-related encephalopathy syndrome
TLS	tumor lysis syndrome
TNF	α-tumor necrosis factor-alpha
ICU	intensive care unit
CRP	C-reactive protein
CBC	complete blood count
DIC	disseminated intravascular coagulation
BBB	blood–brain barrier
ICE	immune effector cell-associated encephalopathy
EEG	electroencephalography
CMV	cytomegalovirus
EBV	Epstein–Barr virus
HHV6	human herpesvirus 6
HSV	herpes simplex virus
HBV	hepatitis B virus
PJP	Pneumocystis jirovecii
HLH	hemophagocytic lymphohistiocytosis
G-CSF	granulocyte colony-stimulating factor
IVIG	intravenous immunoglobulin
G6PD	glucose-6-phosphate dehydrogenase
TME	tumor microenvironment
TB	tumor burden
IFN-ɣ	interferon-gamma
HL	hodgkin lymphoma